Patrick Bossuyt
Overview
Explore the profile of Patrick Bossuyt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rademaker D, de Wit L, van der Wel A, van den Akker E, Braams-Lisman B, Dullemond R, et al.
BMC Pregnancy Childbirth
. 2025 Feb;
25(1):173.
PMID: 39962444
Introduction: Gestational diabetes mellitus (GDM), or hyperglycemia first diagnosed in pregnancy, affects 7-10% of all pregnancies worldwide. Perinatal risk rises with increasing glycemia at oral glucose tolerance test (OGTT). The...
2.
Guni A, Sounderajah V, Whiting P, Bossuyt P, Darzi A, Ashrafian H
JMIR Res Protoc
. 2024 Sep;
13:e58202.
PMID: 39293047
Background: Quality assessment of diagnostic accuracy studies (QUADAS), and more recently QUADAS-2, were developed to aid the evaluation of methodological quality within primary diagnostic accuracy studies. However, its current form,...
3.
Kortlever T, de Klaver W, van der Vlugt M, Meijer G, Dekker E, Bossuyt P
Expert Rev Mol Diagn
. 2023 Nov;
23(12):1221-1232.
PMID: 37930046
Introduction: Fecal Immunochemical Testing (FIT) is a central tool in colorectal cancer (CRC) screening. To improve the selection of individuals for colonoscopy, risk models combining FIT with additional CRC risk...
4.
Rasmussen D, Anstee Q, Torstenson R, Golding B, Patterson S, Brass C, et al.
J Hepatol
. 2022 Dec;
78(4):852-865.
PMID: 36526000
Biomarkers have the potential to accelerate drug development, as early indicators of improved clinical response, to improve patient safety, and for personalised medicine. However, few have been approved through the...
5.
McGenity C, Bossuyt P, Treanor D
J Pathol Inform
. 2022 Oct;
13:100091.
PMID: 36268103
Artificial intelligence (AI) research is transforming the range tools and technologies available to pathologists, leading to potentially faster, personalized and more accurate diagnoses for patients. However, to see the use...
6.
Ropers F, Bossuyt P, Maconochie I, Smit F, Alves C, Greber-Platzer S, et al.
BMJ Open
. 2022 Apr;
12(3):e053382.
PMID: 35361639
Objectives: To compare paediatric healthcare practice variation among five European emergency departments (EDs) by analysing variability in decisions about diagnostic testing, treatment and admission. Design And Population: Consecutive paediatric visits...
7.
8.
Chalkou K, Steyerberg E, Bossuyt P, Subramaniam S, Benkert P, Kuhle J, et al.
Diagn Progn Res
. 2021 Oct;
5(1):17.
PMID: 34706759
Background: Prognosis for the occurrence of relapses in individuals with relapsing-remitting multiple sclerosis (RRMS), the most common subtype of multiple sclerosis (MS), could support individualized decisions and disease management and...
9.
Loh T, Smith A, Bell K, Lord S, Ceriotti F, Jones G, et al.
Clin Chim Acta
. 2021 Oct;
523:407-414.
PMID: 34666026
Analytical performance specifications (APS) for measurands describe the minimum analytical quality requirements for their measurement. These APS are used to monitor and contain the systematic (trueness/bias) and random errors (precision/imprecision)...
10.
Chauvin A, Bossuyt P, Le Conte P
Eur J Emerg Med
. 2021 Sep;
29(2):103-104.
PMID: 34483250
No abstract available.